News

Count yourself lucky if you haven't been a Tilray shareholder over the past five years. It's nice that Tilray is diversified, ...
Tilray Brands is down a lot in 2025 and since its IPO, but it has rallied substantially from its April all-time low. Read why ...
We recently compiled a list of the 12 Cheap Pot Stocks to Buy According to Hedge Funds. Tilray Brands, Inc. is placed first ...
Tilray cultivates and sells cannabis in Canada and exports into the global medical market. It also sells CBD and alcohol. The company is the result of legacy Aphria acquiring legacy Tilray in a ...
Tilray ended fiscal 2025 with record revenue of $821 million, driven by its cannabis, beverage, and wellness divisions. The company remains Canada's top cannabis brand and saw international cannabis ...
Tilray posts record non-cannabis revenues in fiscal 2025, but Q4 sales slip as cannabis weakness pressures overall results.
Two stocks that have been exceptionally hot in recent weeks are Tilray Brands ( TLRY -5.14%) and Opendoor Technologies ( OPEN ...
Detailed price information for Tilray Brands Inc (TLRY-Q) from The Globe and Mail including charting and trades.
Roth Capital Markets analyst Bill Kirk maintained a “Neutral” rating and lowered his 12-month price target to $0.60 from $0.65.
Detailed price information for Tilray Brands Inc (TLRY-Q) from The Globe and Mail including charting and trades.
Full Year 2025 Results Key Financial Results Revenue: US$821.3m (up 4.1% from FY ...
SNDL posted stronger Q2 2025 results, expanded into Europe, and plans to acquire 32 stores, yet the stock remains volatile.